GFAP-BDP as an acute diagnostic marker in traumatic brain injury: Results from the prospective transforming research and clinical knowledge in traumatic brain injury study

Journal of Neurotrauma

Volumn 30, Issue 17, 2013, Pages 1490-1497

  Okonkwo, David O ^a   Yue, John K ^b   Puccio, Ava M ^a   Panczykowski, David M ^a   Inoue, Tomoo ^b   McMahon, Paul J ^a   Sorani, Marco D ^b   Yuh, Esther L ^b   Lingsma, Hester F ^c   Maas, Andrew I R ^d   Valadka, Alex B ^e   Manley, Geoffrey T ^b   Casey, Scott S ^b   Cheong, Maxwell ^b   Cooper, Shelly R ^b   Dams O'connor, Kristen ^f   Gordon, Wayne A ^f   Hricik, Allison J ^a   Hochberger, Kerri ^a   Menon, David K ^g   Mukherjee, Pratik ^b   Sinha, Tuhin K ^b   Schnyer, David M ^h   Vassar, Mary J ^b   more..

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e Seton Brain and Spine Institute   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Clinical trial; Health related quality of life; Outcome; Post concussion syndrome; TBI

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLASGOW COMA SCALE; GROUPS BY AGE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84882623948     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.2883     Document Type: Article

References (32)

1. Vos, P.E., Lamers, K.J., Hendriks, J.C., van Haaren, M., Beems, T., Zimmerman, C., van Geel, W., de Reus, H., Biert, J., and Verbeek, M.M. (2004). Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62, 1303-1310
2. Papa, L., Lewis, L.M., Silvestri, S., Falk, J.L., Giordano, P., Brophy, G.M., Demery, J.A., Liu, M.C., Mo, J., Akinyi, L., Mondello, S., Schmid, K., Robertson, C.S., Tortella, F.C., Hayes, R.L., and Wang, K.K. J. (2012). Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. Trauma Acute Care Surg. 72, 1335-1344
3. Mondello, S., Papa, L., Buki, A., Bullock, M.R., Czeiter, E., Tortella, F.C., Wang, K.K., and Hayes, R.L. (2011). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study. Crit. Care 15, R156
4. Papa, L., Lewis, L.M., Falk, J.L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G.M., Demery, J.A., Dixit, N.K., Ferguson, I., et al. (2012). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483
5. Yue, J.K., Vassar, M.J., Lingsma, H., Cooper, S.R., Yuh, E.L., Mukherjee, P., Puccio, A.M., Gordon, W., Okonkwo, D.O., Valadka, A., Schnyer, D.M., Maas, A., Manley, G.T., Casey, S.S., Cheong, M., Dams-O'Connor, K., Hricik, A.J., Knight, E.E., Kulubya, E.S., Menon, D., Morabito, D.J., Pacheco, J.L., Sinha, T.K. (2013). Transforming research and clinical knowledge in traumatic brain injury (TRACKTBI) pilot: Multicenter implementation of the common data elements for traumatic brain injury. J Neurotrauma [Epub ahead of print]
6. Jagoda, A.S., Bazarian, J.J., Bruns, J.J., Jr, Cantrill, S.V., Gean, A.D., Howard, P.K., Ghajar, J., Riggio, S., Wright, D.W., Wears, R.L., Bakshy, A., Burgess, P., Wald, M.M., Whitson, R.R., American College of Emergency Physicians, and Centers for Disease Control and Prevention (2008). Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann. Emerg. Med. 52, 714-748
7. Manley, G.T., Diaz-Arrastia, R., Brophy, M., Engel, D., Goodman, C., Gwinn, K., Veenstra, T.D., Ling, G., Ottens, A.K., Tortella, F., and Hayes, R.L. (2010). Common data elements for traumatic brain injury: Recommendations from the biospecimens and biomarkers working group. Arch. Phys. Med. Rehabil. 91, 1667-1672
8. Zoltewicz, J.S., Scharf, D., Yang, B., Chawla, A., Newsom, K.J., and Fang, L. (2012). Characterization of antibodies that detect human GFAP after traumatic brain injury. Biomark Insights 7, 71-79
9. Duhaime, A.C., Gean, A.D., Haacke, E.M., Hicks, R., Wintermark, M., Mukherjee, P., Brody, D., Latour, L., Riedy, G., Common Data Elements Neuroimaging Working Group Members, and Pediatric Working Group Members (2010). Common data elements in radiologic imaging of traumatic brain injury. Arch. Phys. Med. Rehabil. 91, 1661-1666
10. Whyte, J., Vasterling, J., and Manley, G.T. (2010). Common data elements for research on traumatic brain injury and psychological health: Current status and future development. Arch. Phys. Med. Rehabil. 91, 1692-1696
11. Wilson, J.T., Pettigrew, L.E., and Teasdale, G.M. (1998). Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. J. Neurotrauma 15, 573-585
12. McCrea, M., Guskiewicz, K.M., Marshall, S.W., Barr, W., Randolph, C., Cantu, R.C., Onate, J.A., Yang, J., and Kelly, J.P. (2003). Acute effects and recovery time following concussion in collegiate football players: The NCAA Concussion Study. J.A.M.A. 290, 2556-2563
13. Prins, M., Alexander, D., Giza, C.C., and Hovda, D. (2012). Repeat mild traumatic brain injury: Mechanisms of cerebral vulnerability. J. Neurotrauma 30, 30-38
14. Mac Donald, C.L., Johnson, A.M., Cooper, D., Nelson, E.C., Werner, N.J., Shimony, J.S., Snyder, A.Z., Raichle, M.E., Witherow, J.R., Fang, R., Flaherty, S.F., and Brody, D.L. (2011). Detection of blastrelated traumatic brain injury in U.S. military personnel. N. Engl. J. Med. 364, 2091-2100
15. Hoge, C.W., McGurk, D., Thomas, J.L., Cox, A.L., Engel, C.C., and Castro, C.A. (2008). Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N. Engl. J. Med. 358, 453-463
16. Bombardier, C.H., Fann, J.R., Temkin, N.R., Esselman, P.C., Barber, J., and Dikmen, S.S. (2010). Rates of major depressive disorder and clinical outcomes following traumatic brain injury. J.A.M.A. 303, 1938-1945
17. Christensen, J., Pedersen, M.G., Pedersen, C.B., Sidenius, P., Olsen, J., and Vestergaard, M. (2009). Long-term risk of epilepsy after traumatic brain injury in children and young adults: A populationbased cohort study. Lancet 373, 1105-1110
18. Nampiaparampil, D.E. (2008). Prevalence of chronic pain after traumatic brain injury: A systematic review. J.A.M.A. 300, 711-719
19. Niogi, S.N., and Mukherjee, P. (2010). Diffusion tensor imaging of mild traumatic brain injury. J. Head Trauma Rehabil. 25, 241-255
20. Vos, P.E., Jacobs, B., Andriessen, T.M., Lamers, K.J., Borm, G.F., Beems, T., Edwards, M., Rosmalen, C.F., and Vissers, J.L. (2010). GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study. Neurology 75, 1786-1793
21. Vos, P.E., van Gils, M., Beems, T., Zimmerman, C., and Verbeek, M.M. (2006). Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur. J. Neurol. 13, 632-638
22. Honda, M., Tsuruta, R., Kaneko, T., Kasaoka, S., Yagi, T., Todani, M., Fujita, M., Izumi, T., and Maekawa, T. (2010). Serum GFAP is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J. Trauma 69, 104-109
23. Pelinka, L.E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., and Redl, H. (2004). GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. J. Neurotrauma 21, 1553-1561
24. Czeiter, E., Mondello, S., Kovacs, N., Sandor, J., Gabrielli, A., Schmid, K., Tortella, F., Wang, K.K., Hayes, R.L., Barzo, P., Ezer, E., Doczi, T., and Buki, A. (2012). Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J. Neurotrauma 29, 1770-1778
25. Maisel, A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., Omland, T., Storrow, A.B., Abraham, W.T., Wu, A.H., Clopton, P., Steg, P.G., Westheim, A., Knudsen, C.W., Perez, A., Kazanegra, R., Herrmann, H.C., McCullough, P.A., and Breathing Not Properly Multinational Study Investigators (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl. J. Med. 347, 161-167
26. Peacock, W.F., 4th, De Marco, T., Fonarow, G.C., Diercks, D., Wynne, J., Apple, F.S., Wu, A.H., and ADHERE Investigators (2008). Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med. 358, 2117-2126
27. Reichlin, T., Hochholzer, W., Bassetti, S., Steuer, S., Stelzig, C., Hartwiger, S., Biedert, S., Schaub, N., Buerge, C., Potocki, M., Noveanu, M., Breidthardt, T., Twerenbold, R., Winkler, K., Bingisser, R., and Mueller, C. (2009). Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361, 858-867
28. Vissers, J.L., Mersch, M.E., Rosmalen, C.F., van Heumen, M.J., van Geel, W.J., Lamers, K.J., Rosmalen, F.M., Swinkels, L.M., Thomsen, J., and Herrmann, M. (2006). Rapid immunoassay for the determination of GFAP in serum. Clin. Chim. Acta 366, 336-340
29. Van Geel, W.J., de Reus, H.P., Nijzing, H., Verbeek, M.M., Vos, P.E., and Lamers, K.J. (2002). Measurement of GFAP in blood: An analytical method. Clin. Chim. Acta 326, 151-154
30. Reinsfelt, B., Ricksten, S.E., Zetterberg, H., Blennow, K., Fredén-Lindqvist, J., and Westerlind, A. (2012). Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann. Thorac. Surg. 94, 549-555
31. Savage, W.J., Barron-Casella, E., Fu, Z., Dulloor, P., Williams, L., Crain, B.J., White, D.A., Jennings, J.M., Van Eyk, J.E., Debaun, M.R., Everett, A., and Casella, J.F. (2011). Plasma GFAP levels in children with sickle cell disease. Am. J. Hematol. 86, 427-429
32. Seco, M., Edelman, J.J., Wilson, M.K., Bannon, P.G., and Vallely, M.P. (2012). Serum biomarkers of neurologic injury in cardiac operations. Ann. Thorac. Surg. 94,1026-1033